Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells

Abstract Background Leukemia stem cells (LSCs) are responsible for the initiation and perpetuation of acute myeloid leukemia (AML), and also represent leukemia relapse reservoirs with limited therapeutic approaches. Thus, additional treatment strategies are medical unmet needs to eliminate LSCs. Met...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Haijun Zhao, Yuelong Jiang, Fusheng Lin, Mengya Zhong, Jinshui Tan, Yong Zhou, Long Liu, Guowei Li, Manman Deng, Bing Xu
Formáid: Artigo
Teanga:Inglês
Foilsithe: BMC 2022-05-01
Sraith:Experimental Hematology & Oncology
Ábhair:
Leukemia stem and progenitor cells
Acute myeloid leukemia (AML)
Apatinib
Chidamide
VEGFR
Bcl2
Rochtain Ar Líne:https://doi.org/10.1186/s40164-022-00282-1
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla